|
MammoSite®
Breast Cancer
courtesy of Cytyc Corporation
and affiliates
|
Breast Cancer is the most common cancer in women accounting for 32% of all new cancer cases in America and the second leading cause of cancer deaths representing 15% of all female cancer deaths.
For patients diagnosed with early stage breast cancer, effective cancer treatments are available for breast conservation therapy (BCT).
Brachytherapy is one form of radiation treatment involving the use of radioactive sources that are placed temporarily or permanently in the site of the cancerous tissue.
Accelerated Partial Breast Irradiation (APBI) is part of a multidisciplinary approach to breast conservation therapy. The MammoSite Radiation Therapy System (RTS) is a widely used method of APBI and relatively new and innovative technique of delivering radiation from inside the breast directly to tissue where cancer is most likely to recur.
The Advantages to MammoSite Radiation Therapy:
- Treatment can be completed in up to 5 days.
- High doses of radiation are delivered to the lumpectomy cavity where cancer is most likely to recur and limits the amount of surrounding normal tissues exposed to radiation, potentially minimizing side effects and improving cosmesis.
- Treatment is delivered on an outpatient basis without the need for hospitalization.
- Cosmesis is good to excellent in more than 88% of patients at two years after treatment.
Breast brachytherapy as the sole method of radiation therapy after breast conserving surgery offers improved convenience, quality of life, and in breast control rates of 95%.
Click here for manufacturer's website.
|
